Endo international plc (ENDP)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Net pharmaceutical product sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

519,843

584,303

535,744

Devices revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

111,244

125,971

122,652

Other revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30,232

1,874

98

TOTAL REVENUES, NET

820,405

764,800

729,426

699,727

720,411

786,389

745,466

714,696

700,527

768,640

786,887

875,731

1,037,600

1,241,513

884,335

920,887

963,539

1,073,697

745,727

735,166

714,128

662,877

654,116

592,848

470,842

92,720

661,319

712,148

658,494

COSTS AND EXPENSES:
Cost of revenues

388,799

400,056

389,165

388,208

391,909

433,214

412,965

381,905

403,598

505,645

514,522

539,401

668,962

756,578

557,472

632,218

688,705

810,068

442,459

438,858

384,266

374,180

341,193

303,445

212,679

100,973

257,836

273,413

254,381

Selling, general and administrative

166,768

160,671

168,329

152,297

151,123

167,422

163,791

148,157

166,667

161,199

135,880

155,555

177,240

212,568

186,735

193,070

178,355

212,014

163,221

154,491

211,578

134,653

148,901

124,366

160,066

-88,583

191,362

244,302

227,232

Research and development

31,615

34,379

36,519

26,348

33,486

25,395

39,683

82,102

38,646

48,545

39,644

40,869

43,009

46,206

44,885

50,589

41,692

43,989

21,327

18,984

17,897

30,543

20,813

30,406

30,946

-11,384

36,687

33,393

38,769

Litigation-related and other contingencies, net

17,176

15,300

14,414

-10,315

-6

1,561

1,750

-19,620

2,500

-171,974

-12,352

-2,600

936

-4,765

18,256

5,259

5,200

17,207

0

6,875

13,000

34,999

3,131

3,954

0

-149,648

30,895

59,971

68,232

Asset Impairment Charges

97,785

267,400

4,766

88,438

165,448

303,539

142,217

22,767

448,416

130,446

94,924

725,044

203,962

3,518,085

93,504

39,951

129,625

139,859

923,607

70,243

7,000

22,542

0

0

0

27,255

807

2,849

1,100

Business Combination, Acquisition Related Costs

12,462

-19,100

16,025

-5,507

-37,501

8,630

1,288

5,161

6,835

26,375

16,641

4,190

10,880

7,400

19,476

48,171

12,554

54,073

-27,688

44,225

34,640

9,765

2,732

19,618

45,269

3,738

1,493

1,825

558

Interest expense, net

132,877

-

-

-

132,675

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

OPERATING LOSS FROM CONTINUING OPERATIONS

-

-

-

-

-

-

-

-

-

-

-2,372

-586,728

-67,389

-3,294,559

-35,993

-48,371

-92,592

-203,513

-777,199

1,490

45,747

56,195

137,346

111,059

21,882

210,369

142,239

96,395

68,222

Interest Income (Expense), Net

-

-

-136,903

-134,809

-

-135,760

-131,847

-130,059

-123,990

-126,961

-127,521

-121,747

-111,999

-111,783

-112,184

-111,919

-116,793

-123,018

-96,446

-80,611

-73,139

-59,589

-61,950

-52,183

-53,392

-43,915

-43,081

-42,334

-44,276

LOSS ON EXTINGUISHMENT OF DEBT

0

0

0

0

119,828

0

0

0

0

-

0

-51,734

-

-

0

0

-

-25,595

-40,909

0

-980

-105

-2,027

-20,089

-9,596

0

0

0

-11,312

Nonoperating Income (Expense)

13,974

3,731

-16,203

597

-4,802

18,737

1,507

28,831

2,878

6,180

2,097

6,709

2,037

740

2,866

-5,175

1,907

-1,102

-50,091

-24,493

11,995

13,596

5,724

6,596

6,408

3,418

14,672

16,700

18,269

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest

21,249

-224,541

-24,070

-94,584

-1,709

-267,273

-143,068

-46,244

-482,247

-424,357

-127,796

-753,500

-177,351

-3,405,602

-145,311

-165,465

-207,478

-353,228

-964,645

-103,614

-16,377

10,097

79,093

45,383

-34,698

169,872

113,830

70,761

30,903

Income Tax Expense (Benefit)

-136,332

-16,052

17,361

3,468

10,903

-1,794

3,003

6,235

15,491

-152,776

-28,109

-57,480

-11,928

-72,277

46,185

-555,277

-118,715

-796,937

-160,939

-12,720

-166,869

-9,384

30,140

4,808

12,703

60,825

44,655

29,012

9,250

Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent

157,581

-208,489

-41,431

-98,052

-12,612

-265,479

-146,071

-52,479

-497,738

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent

-27,651

-10,154

-37,984

-7,953

-5,961

-26,429

-27,134

-8,388

-7,751

-96,836

3,017

-700,498

-8,405

-4,531

-27,423

-46,216

-45,108

-562,302

-246,782

-159,632

-226,210

-72,724

-301,002

-20,189

-385,877

-870,790

-14,560

6,362

4,950

Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest

-

-

-

-

-

-

-

-

-

-

-99,687

-696,020

-165,423

-3,333,325

-191,496

389,812

-88,763

443,709

-803,706

-90,894

150,492

19,481

48,953

40,575

-47,401

109,047

69,175

41,749

21,653

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,337,856

-218,919

343,596

-133,871

-118,593

-1,050,488

-250,526

-75,718

-53,243

-252,049

20,386

-433,278

-761,743

54,615

48,111

26,603

Net Income (Loss) Attributable to Noncontrolling Interest

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

18

-2

-130

-46

-107

0

240

35

-774

3,634

14,167

14,392

13,112

11,254

Net Income (Loss) Attributable to Parent

129,930

-218,643

-79,415

-106,005

-18,573

-291,908

-173,205

-60,867

-505,489

-368,417

-96,670

-1,396,518

-173,828

-3,337,856

-218,919

343,578

-133,869

-118,463

-1,050,442

-250,419

-75,718

-53,483

-252,084

21,160

-436,912

-775,910

40,223

34,999

15,349

NET INCOME (LOSS) PER SHARE—BASIC:
Continuing operations (in dollars per share)

0.69

-0.92

-0.18

-0.43

-0.06

-1.18

-0.65

-0.23

-2.23

-1.21

-0.45

-3.12

-0.74

-14.97

-0.86

1.75

-0.40

1.92

-3.84

-0.49

0.89

0.20

0.32

0.27

-0.37

0.96

0.61

0.37

0.19

Discontinued operations (in dollars per share)

-0.12

-0.04

-0.17

-0.04

-0.02

-0.13

-0.12

-0.04

-0.03

-0.44

0.02

-3.14

-0.04

-0.02

-0.12

-0.21

-0.20

-2.69

-1.18

-0.86

-1.34

-0.20

-1.96

-0.13

-3.04

-7.81

-0.26

-0.06

-0.05

Basic (in dollars per share)

0.57

-0.96

-0.35

-0.47

-0.08

-1.31

-0.77

-0.27

-2.26

-1.65

-0.43

-6.26

-0.78

-14.99

-0.98

1.54

-0.60

-0.77

-5.02

-1.35

-0.45

0.00

-1.64

0.14

-3.41

-6.85

0.35

0.31

0.14

NET INCOME (LOSS) PER SHARE—DILUTED:
Continuing operations (in dollars per share)

0.68

-0.92

-0.18

-0.43

-0.06

-1.18

-0.65

-0.23

-2.23

-1.21

-0.45

-3.12

-0.74

-14.97

-0.86

1.75

-0.40

1.96

-3.84

-0.49

0.85

0.21

0.31

0.25

-0.37

0.89

0.58

0.36

0.19

Discontinued operations (in dollars per share)

-0.12

-0.04

-0.17

-0.04

-0.02

-0.13

-0.12

-0.04

-0.03

-0.44

0.02

-3.14

-0.04

-0.02

-0.12

-0.21

-0.20

-2.75

-1.18

-0.86

-1.28

0.06

-1.90

-0.12

-3.04

-7.38

-0.25

-0.06

-0.05

Diluted (in dollars per share)

0.56

-0.96

-0.35

-0.47

-0.08

-1.31

-0.77

-0.27

-2.26

-1.65

-0.43

-6.26

-0.78

-14.99

-0.98

1.54

-0.60

-0.79

-5.02

-1.35

-0.43

0.27

-1.59

0.13

-3.41

-6.49

0.33

0.30

0.14

WEIGHTED AVERAGE SHARES:
Weighted Average Number of Shares Outstanding, Basic

227,198

226,787

226,598

226,221

224,594

224,353

224,132

223,834

223,521

223,321

223,299

223,158

223,014

222,868

222,767

222,667

222,302

224,145

209,274

185,328

169,653

153,772

153,309

152,368

128,135

115,106

114,327

112,531

111,216

Weighted Average Number of Shares Outstanding, Diluted

233,014

226,787

226,598

226,221

224,594

224,353

224,132

223,834

223,521

223,321

223,299

223,158

223,014

222,672

222,767

222,863

222,302

216,973

209,274

185,328

176,825

176,441

158,975

163,369

128,135

128,645

120,261

117,221

113,189